Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-09-13

Clinical Trial Update: 0.05 Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 0.05 mg vs 0.1 mg intrathecal morphine to reduce postoperative morphine requirements after vaginal hysterectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (intrathecal) (morphine)

Snippet

Sponsor: Mahidol University | Conditions: Pain, Vaginal Hysterectomy | Phase 4 | Status: UNKNOWN